Your browser doesn't support javascript.
loading
Prevention of Ebola virus disease through vaccination: where we are in 2018.
Lévy, Yves; Lane, Clifford; Piot, Peter; Beavogui, Abdul Habib; Kieh, Mark; Leigh, Bailah; Doumbia, Seydou; D'Ortenzio, Eric; Lévy-Marchal, Claire; Pierson, Jerome; Watson-Jones, Deborah; Nguyen, Vinh-Kim; Larson, Heidi; Lysander, Julia; Lacabaratz, Christine; Thiebaut, Rodolphe; Augier, Augustin; Ishola, David; Kennedy, Stephen; Chêne, Geneviève; Greenwood, Brian; Neaton, James; Yazdanpanah, Yazdan.
Afiliação
  • Lévy Y; French Institute for Health and Medical Research (Inserm), Paris, France. Electronic address: yves.levy@inserm.fr.
  • Lane C; National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
  • Piot P; London School of Hygiene & Tropical Medicine, London, UK.
  • Beavogui AH; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Mafèrinyah, Guinea.
  • Kieh M; Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia.
  • Leigh B; College of Medicine and Allied Health Sciences (COMAHS), University of Sierra Leone, Freetown, Sierra Leone.
  • Doumbia S; University of Sciences, Technique and Technology of Bamako, Bamako, Mali.
  • D'Ortenzio E; French Institute for Health and Medical Research (Inserm), Paris, France.
  • Lévy-Marchal C; French Institute for Health and Medical Research (Inserm), Paris, France.
  • Pierson J; National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
  • Watson-Jones D; London School of Hygiene & Tropical Medicine, London, UK.
  • Nguyen VK; Graduate Institute of International and Development Studies, Geneva, Switzerland.
  • Larson H; London School of Hygiene & Tropical Medicine, London, UK.
  • Lysander J; Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia.
  • Lacabaratz C; French Institute for Health and Medical Research (Inserm), Paris, France.
  • Thiebaut R; French Institute for Health and Medical Research (Inserm), Paris, France.
  • Augier A; The Alliance for International Medical Action, Dakar, Senegal.
  • Ishola D; London School of Hygiene & Tropical Medicine, London, UK.
  • Kennedy S; Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia.
  • Chêne G; French Institute for Health and Medical Research (Inserm), Paris, France.
  • Greenwood B; London School of Hygiene & Tropical Medicine, London, UK.
  • Neaton J; School of Public Health, University of Minnesota, Minneapolis, MN, USA.
  • Yazdanpanah Y; French Institute for Health and Medical Research (Inserm), Paris, France.
Lancet ; 392(10149): 787-790, 2018 09 01.
Article em En | MEDLINE | ID: mdl-30104048
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Vacinação / Doença pelo Vírus Ebola / Vacinas contra Ebola Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Lancet Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Vacinação / Doença pelo Vírus Ebola / Vacinas contra Ebola Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Lancet Ano de publicação: 2018 Tipo de documento: Article